Trial Profile
Pharmacokinetic, Randomized, Open-label, Single-dose, 3-way Cross-over Study of Intravenous and Inhaled Glycopyrrolate With or Without Charcoal Block Ingestion in Healthy Volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Glycopyrrolate (Primary) ; Glycopyrrolate
- Indications Chronic obstructive pulmonary disease
- Focus Pharmacokinetics
- Acronyms Gly1
- 23 Aug 2010 New trial record